DKSH Partners with Aurobindo Pharma Limited to Bring Antibiotic, Antihypertensive, and Respiratory Treatments to Cambodia

Cambodia, Phnom Penh, February 14, 2025 - DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in Asia and beyond, has signed an agreement with Aurobindo Pharma Ltd, an integrated global pharmaceutical company providing a wide range of generic pharmaceuticals, branded specialty pharmaceuticals and active pharmaceutical ingredients, in Cambodia. As part of the partnership, DKSH will expand Aurobindo Pharma’s products, including anti-biotic, antihypertensive, and respiratory medicines to the Cambodian market.

DKSH Cambodia’s experienced teams and broad distribution network will ensure that Aurobindo Phar-ma’s products reach modern and traditional trade, hospitals, clinics, other medical channels, and pa-tients in need nationwide.

Philip Wray, Vice President of Healthcare at DKSH Cambodia, said: “We are delighted to be Aurobindo Pharma’s trusted and strategic partner. Through this partnership, we will provide high-quality antibiotics, antihypertensive, and respiratory medicines from a world-renowned pharmaceutical leader, aimed at enhancing patient outcomes across the Cambodian market. This collaboration underscores our commitment to improving health and quality of life for patients, in alignment with DKSH’s purpose of enriching people’s lives and our mission of providing healthcare for all.”.